Ohio State Navbar

The Ohio State University

  • Ohio State's Wexner Medical Center
  • OSUCCC - James
  • Ohio State's College of Medicine
Sign In

RSS Feed Regenerative Medicine News


StemCells, Inc. Partners With R Biomedical to Develop and Commercialize Reagents for Human iPS Cell Research 

 

StemCells, Inc. Partners With R Biomedical to Develop and Commercialize Reagents for Human iPS Cell Research

Oct. 30, 2012 - (StemCells, Inc.) - "StemCells, Inc. announced today that it has partnered with R Biomedical, anEdinburgh, UK-based biomedical company, to develop and commercialize a range of cell lines and reagents to facilitate human induced pluripotent stem (iPS) cell-based research for regenerative medicine applications."   Read Full Article
​

 

Posted on 13-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: